» Articles » PMID: 39232779

Effect of Salt Substitution on Fracture-a Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS)

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2024 Sep 5
PMID 39232779
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Associations of dietary sodium and potassium intake with fracture risk are inconsistent and the effects of salt substitute on fracture incidence are unknown. We assessed the effect of salt substitute compared to regular salt intake on fracture incidence using data from the Salt Substitute and Stroke Study (SSaSS).

Methods: SSaSS was a cluster-randomized controlled trial conducted in 600 villages in northern China. Villages were randomly allocated into intervention and control groups in a 1:1 ratio. Salt substitute was provided to intervention villages and control villages continued regular salt use for 5 years. The primary outcome for this secondary analysis was the incidence of all fractures. Secondary outcomes included incidence of vertebral fracture, non-vertebral fracture, and fracture of unknown or non-specific location.

Results: 20,995 participants were included in this study, and 821 fractures occurred during follow-up. Intention-to-treat analyses showed no differences between the salt substitute and regular salt groups in the incidence of all fractures (rate ratio (RR) 0.96; 95% CI 0.81 to 1.14), vertebral fracture (RR 0.82; 95% CI 0.53 to 1.26), non-vertebral fracture (RR 1.05; 95% CI 0.86 to 1.29), or fracture of unknown or non-specific location (RR 0.80; 95% CI 0.54 to 1.18).

Conclusions: Use of salt substitute compared to regular salt had no detectable effect on the incidence of fracture in a population at high risk of cardiovascular disease and fracture.

Trial Registration: ClinicalTrials.gov, NCT02092090. Registered on March 12, 2014.

References
1.
Hong S, Choi J, Park J, Lee C . The association between dietary sodium intake and osteoporosis. Sci Rep. 2022; 12(1):14594. PMC: 9418184. DOI: 10.1038/s41598-022-18830-4. View

2.
Watts N, Manson J . Osteoporosis and Fracture Risk Evaluation and Management: Shared Decision Making in Clinical Practice. JAMA. 2016; 317(3):253-254. DOI: 10.1001/jama.2016.19087. View

3.
Neal B, Tian M, Li N, Elliott P, Yan L, Labarthe D . Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial. Am Heart J. 2017; 188:109-117. DOI: 10.1016/j.ahj.2017.02.033. View

4.
Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C . Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020; 15(1):59. PMC: 7166207. DOI: 10.1007/s11657-020-0706-y. View

5.
Cohen A, Roe F . Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem Toxicol. 2000; 38(2-3):237-53. DOI: 10.1016/s0278-6915(99)00145-3. View